Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

US Patent Number : 11318121

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215833

Patent Use Code : U-3345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-15

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

US Patent Number : 10406240

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215833

Patent Use Code : U-3345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-15

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

US Patent Number : 11951190

Drug Substance Claim :

Drug Product Claim :

Application Number : 215833

Patent Use Code : U-3345

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

US Patent Number : 10398791

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215833

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-10-17

blank